Authors
Mim Senft, CWWS, GBA, AAI, RYT, is the chief executive officer (CEO) of Motivity Partnerships, Inc. a consulting firm that helps organizations create integrated, actionable and measurable engagement, health and gender/D&I strategy for their workforce. She is also is Co-Founder/CEO of Global Women 4 Wellbeing (GW4W), a nonprofit organization focused on empowering more healthy female leadership at all levels.
Johns Hopkins School of Medicine faculty
Jeff Stark, MD, is vice president and head of medical immunology, UCB. He is also a rheumatologist by training and leads UCB’s medical affairs team across the key focus areas of dermatology and rheumatology.
Advertisement
Advertisement
Trending on AJMC
1
Tec-Dara Demonstrates Superior 3-Year PFS vs Standard Therapy in Functional High-Risk Myeloma: Rahul Banerjee, MD
2
MRD-Guided CLL Treatment Duration: Personalization or Malpractice?
3
Global Hematology Trials Ensure Research Stays Applicable, Flexible, Patient-Centered
4
Blinatumomab Improves Outcomes, Toxicity in High-Risk Pediatric ALL: Martin Schrappe, MD, PhD
5


